Patents by Inventor Deepak BEHERA

Deepak BEHERA has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • CD8 IMAGING CONSTRUCTS AND METHODS OF USE THEREOF
    Publication number: 20220001043
    Abstract: Antigen binding constructs that bind to CD8, as well as formulations and methods of using them, are described herein.
    Type: Application
    Filed: September 27, 2019
    Publication date: January 6, 2022
    Inventors: Ian Andrew Wilson, Deepak Behera, William Huy Le
  • Highly selective sigma receptor ligands and radioligands as probes in nociceptive processing and the pathphysiological study of memory deficits and cognitive disorders
    Patent number: 9724435
    Abstract: A method for localizing and quantifying S1R role in nociceptive processing; for providing a guide to providing an analgesic therapy; of using an S1R selective ligand as a biomarker for pathphysiological study of memory deficits and cognitive disorders; or of detecting increased S1R density at the site of nerve injury arising from neuropathic pain comprising using as a probe at least one SR1 selective compound or radioligand of the general formula III?, or IV?:
    Type: Grant
    Filed: March 4, 2014
    Date of Patent: August 8, 2017
    Assignees: THE UNIVERSITY OF MISSISSIPPI, THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY
    Inventors: Christopher R. McCurdy, Christophe Mesangeau, Frederick T. Chin, Michelle L. James, Bin Shen, Sanjiv Gambhir, Sandip Biswal, Deepak Behera
  • HIGHLY SELECTIVE SIGMA RECEPTOR LIGANDS AND RADIOLIGANDS AS PROBES IN NOCICEPTIVE PROCESSING AND THE PATHPHYSIOLOGICAL STUDY OF MEMORY DEFICITS AND COGNITIVE DISORDERS
    Publication number: 20140328755
    Abstract: A method for localizing and quantifying S1R role in nociceptive processing; for providing a guide to providing an analgesic therapy; of using an S1R selective ligand as a biomarker for pathphysiological study of memory deficits and cognitive disorders; or of detecting increased S1R density at the site of nerve injury arising from neuropathic pain comprising using as a probe at least one SR1 selective compound or radioligand of the general formula III?, or IV?:
    Type: Application
    Filed: March 4, 2014
    Publication date: November 6, 2014
    Inventors: Christopher R. MCCURDY, Christophe MESANGEAU, Frederick T. CHIN, Michelle L. JAMES, Bin SHEN, Sanjiv GAMBHIR, Sandip BISWAL, Deepak BEHERA